- Home
- BXSL vs TECH Comparison
BXSL vs TECH Comparison
Compare BXSL & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BXSL | TECH |
|---|---|---|
| Founded | 2018 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.4B | 9.5B |
| IPO Year | N/A | 1989 |
Fundamental Metrics
Financial Performance| Metric | BXSL | TECH |
|---|---|---|
| Price | $27.62 | $57.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 14 |
| Target Price | $29.38 | ★ $71.23 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 11-10-2025 | 02-04-2026 |
| Dividend Yield | ★ 11.10% | 0.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.66 | 0.49 |
| Revenue | ★ $1,413,784,000.00 | $1,216,732,000.00 |
| Revenue This Year | $9.05 | $2.33 |
| Revenue Next Year | $0.28 | $7.05 |
| P/E Ratio | ★ $10.44 | $117.08 |
| Revenue Growth | ★ 10.58 | 3.85 |
| 52 Week Low | $24.85 | $46.01 |
| 52 Week High | $34.64 | $79.28 |
Technical Indicators
Market Signals| Indicator | BXSL | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 50.29 | 38.72 |
| Support Level | $28.03 | $56.59 |
| Resistance Level | $28.59 | $61.20 |
| Average True Range (ATR) | 0.43 | 2.00 |
| MACD | -0.07 | -0.63 |
| Stochastic Oscillator | 26.42 | 6.35 |
Price Performance
Historical ComparisonAbout BXSL Blackstone Secured Lending Fund of Beneficial Interest
Blackstone Secured Lending Fund is a non-diversified, closed-end management investment company. The investment objectives of the company are to generate current income and, to a lesser extent, long-term capital appreciation. The company seeks to achieve its investment objectives by investing in originated loans and other securities, including syndicated loans of private U.S. companies, typically in the form of first lien senior secured and unitranche loans, unsecured and subordinated loans, and other securities.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.